Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A Johnson

Showing results (311-320 of 681) with videos related to

Pageof 69
Sort By:
Vox Sanguinis|October 1, 1977
Comparison of low-molecular-weight products following reaction of C3-C3b with C3b inactivator and with trypsinJ Freedman, H Chaplin, C A Johnson, et al.
American Journal of Public Health|July 1, 1997
Targeted tobacco markets: outdoor advertising in Los Angeles minority neighborhoodsJ L Stoddard, C A Johnson, T Boley-Cruz, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1995
Serum advanced glycosylation end-products in patients on hemodialysis and CAPDA Ateshkadi, C A Johnson, H W Founds, et al.
American Journal of Ophthalmology|December 15, 1989
Visual field damage in normal-tension and high-tension glaucomaB C Chauhan, S M Drance, G R Douglas, et al.
Investigative Ophthalmology & Visual Science|July 1, 1982
Monocular deprivation in humans: a study of identical twinsC A Johnson, R B Post, L M Chalupa, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1981
Management of fulminating thrombotic thrombocytopenic purpuraS J Updike, M J Bozdech, C A Johnson, et al.
International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology|November 1, 1986
Win some, lose some: parental hypertension and heart rate change in an incentive versus response cost paradigmJ L Hastrup, C A Johnson, A P Hotchkiss, et al.
Journal of Medicinal Chemistry|August 7, 1992
Synthesis and antifolate evaluation of 10-ethyl-5-methyl-5,10- dideazaaminopterin and an alternative synthesis of 10-ethyl-10- deazaaminopterin (edatrexate)J R Piper, C A Johnson, G M Otter, et al.
Ophthalmology|March 1, 1989
Visual field loss in migraineR A Lewis, N Vijayan, C Watson, et al.
The Orthopedic Clinics of North America|January 1, 1973
Neuropathic arthropathy (Charcot forefeet) in alcoholicsH L Thornhill, R W Richter, M L Shelton, et al.
Pageof 69

Showing results (311-320 of 681) with videos related to

Sort By:
Pageof 69
Vox Sanguinis|October 1, 1977
Comparison of low-molecular-weight products following reaction of C3-C3b with C3b inactivator and with trypsinJ Freedman, H Chaplin, C A Johnson, et al.
American Journal of Public Health|July 1, 1997
Targeted tobacco markets: outdoor advertising in Los Angeles minority neighborhoodsJ L Stoddard, C A Johnson, T Boley-Cruz, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1995
Serum advanced glycosylation end-products in patients on hemodialysis and CAPDA Ateshkadi, C A Johnson, H W Founds, et al.
American Journal of Ophthalmology|December 15, 1989
Visual field damage in normal-tension and high-tension glaucomaB C Chauhan, S M Drance, G R Douglas, et al.
Investigative Ophthalmology & Visual Science|July 1, 1982
Monocular deprivation in humans: a study of identical twinsC A Johnson, R B Post, L M Chalupa, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1981
Management of fulminating thrombotic thrombocytopenic purpuraS J Updike, M J Bozdech, C A Johnson, et al.
International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology|November 1, 1986
Win some, lose some: parental hypertension and heart rate change in an incentive versus response cost paradigmJ L Hastrup, C A Johnson, A P Hotchkiss, et al.
Journal of Medicinal Chemistry|August 7, 1992
Synthesis and antifolate evaluation of 10-ethyl-5-methyl-5,10- dideazaaminopterin and an alternative synthesis of 10-ethyl-10- deazaaminopterin (edatrexate)J R Piper, C A Johnson, G M Otter, et al.
Ophthalmology|March 1, 1989
Visual field loss in migraineR A Lewis, N Vijayan, C Watson, et al.
The Orthopedic Clinics of North America|January 1, 1973
Neuropathic arthropathy (Charcot forefeet) in alcoholicsH L Thornhill, R W Richter, M L Shelton, et al.
Pageof 69